Evidence map›Paper›PMID 33117157›Full record

ArticleFrontiers in pharmacology2020

Positive RT-PCR Test Results in 420 Patients Recovered From COVID-19 in Wuhan: An Observational Study.

Shaobin He, Jiaxing Tian, Xiaodong Li, Yana Zhou, Mingzhong Xiao, Ying Zhang, Xiaojun Min, Xiuyang Li, De Jin, Qing Zhang and 15 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Hyperlipidemia, COVID-19 and acute pancreatitis: A tale of three entities.The American journal of the medical sciences · 2022
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 6 institutions in 1 country.

Shaobin HeHubei Hospital of Traditional Chinese Medicine, Wuhan, China.
Jiaxing TianDepartments of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Xiaodong LiHubei University of Chinese Medicine, Wuhan, Wuhan, China.
Yana ZhouDepartment of Oncology, Hubei Hospital of Traditional Chinese Medicine, Wuhan, China.
Mingzhong XiaoLiver Disease Branch, Hubei Hospital of Traditional Chinese Medicine, Wuhan, China.
Ying ZhangCenter for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Xiaojun MinDepartment of Endocrinology, Hubei Hospital of Traditional Chinese Medicine, Wuhan, China.
Xiuyang LiMedical Affairs Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
De JinDepartments of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Qing ZhangDepartment of Orthopedics, Hubei Hospital of Traditional Chinese Medicine, Wuhan, China.
Yujiao ZhengDepartments of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Jia KeDepartment of Pulmonary Medicine, Hubei Hospital of Traditional Chinese Medicine, Wuhan, China.
Qingwei LiDepartments of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Junxiu TaoLiver Disease Branch, Hubei Hospital of Traditional Chinese Medicine, Wuhan, China.
Ping SongInternational Cooperation Department, China Academy of Chinese Medical Sciences, Beijing, China.
Han WangDepartments of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Yi LvLiver Disease Branch, Hubei Hospital of Traditional Chinese Medicine, Wuhan, China.
Qiyou DingDepartments of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Shuang TangDepartments of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Jiaran LinDepartments of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Zhaoyuan JiangInternational Cooperation Department, China Academy of Chinese Medical Sciences, Beijing, China.
Zijun ZhangInternational Cooperation Department, China Academy of Chinese Medical Sciences, Beijing, China.
Juexian SongDepartment of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
Fengmei LianDepartments of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Xiaolin TongDepartments of Endocrinology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNHubei Provincial Hospital of Traditional Chinese Medicine · CNGuang’anmen Hospital · CNBeijing University of Chinese Medicine · CNHubei University of Chinese Medicine · CNCapital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveDuring the follow-up of patients recovered from coronavirus disease 2019 (COVID-19) in the quarantine and observation period, some of the cured patients showed positive results again. The recurrent positive RT-PCR test results drew widespread concern. We observed a certain number of cured COVID-19 patients with positive RT-PCR test results and try to analyze the factors that caused the phenomenon.

methodsWe conducted an observational study in COVID-19 patients discharged from 6 rehabilitation stations in Wuhan, China. All observed subjects met the criteria for hospital discharge and were in quarantine. Data regarding age, sex, body mass index (BMI), course of disease, comorbidity, smoking status and alcohol consumption, symptoms in and out of quarantine, and intervention were collected from the subjects' medical records and descriptively analyzed. The main outcome of this study was the RT-PCR test result of the observed subjects at the end of quarantine (negative or positive). Logistic regression analysis was used to identify the influencing factors related to recurrent positive RT-PCR test results.

resultsIn this observational study, 420 observed subjects recovered from COVID-19 were included. The median age was 56 years, 63.6% of the subjects were above 50 years old, and 50.7% (213/420) were female. The most common comorbidities were hypertension [26.4% (111/420)], hyperlipidemia [10.7% (45/420)], and diabetes [10.5% (44/420)]. 54.8% (230/420) manifested one or more symptoms at the beginning of the observation period, the most common symptoms were cough [27.6% (116/420)], shortness of breath 23.8% (100/420)], and fatigue [16.2% (68/420)], with fever rare [2.6% (11/420)]. A total of 325 subjects were exposed to comprehensive intervention; 95 subjects were absence of intervention. The recurrence rate of positive RT-PCR test results with comprehensive intervention was 2.8% (9/325), and that with no intervention was 15.8% (15/95). The results of logistic regression analysis showed that after adjusted for factors such as age, sex, and comorbidity and found out that comprehensive intervention was correlated with the recurrent positive RT-PCR test results. There was appreciably less recurrence in the comprehensive intervention group.

conclusionsThe factors related to positive RT-PCR test results in observed subjects recovered from COVID-19 were age, comorbidity, and comprehensive intervention, among which comprehensive intervention might be a protective factor. CLINICAL

trial registrationChictr.org.cn, identifier ChiCTR2000030747.

Indexed as

comprehensive interventioncoronavirus disease 2019correlation factor analysispositive RT-PCR test resultrecurrence rate

Identifiers

PMID33117157
PMCPMC7577046
OpenAlexW3091979525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.